Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR

Alterations in the expression of Fas (CD95/APO-1) and its ligand (FasL) have been demonstrated in various types of cancers as a mechanism for tumour cell to escape from the immune system. In the present study, we evaluated the expression of the Fas and FasL genes in a wide range of primary gynaecolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, H, Koizumi, T, Sugimoto, T, Chakraborty, S, Ichimura, T, Hasegawa, K, Nishimura, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374514/
https://www.ncbi.nlm.nih.gov/pubmed/10817504
http://dx.doi.org/10.1054/bjoc.2000.1118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374514/
https://www.ncbi.nlm.nih.gov/pubmed/10817504
http://dx.doi.org/10.1054/bjoc.2000.1118

Ejemplares similares